IP Library Granted Patent US 11,202,904
Granted Patent B2
US 11,202,904 · App. 16/280,057 · Granted Dec 21, 2021

Positioning methods for intravascular electrode arrays for neuromodulation

Inventor: Stephen C Masson (Raleigh, NC)
Assignee: NuXcel Limited
A61N1/056A61B17/3468A61N1/05A61N1/36053A61N1/36128
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,202,904
App. No.
16/280,057
Granted
Dec 21, 2021
Kind
B2
Abstract

A method for positioning an electrode array of a neuromodulation catheter at a target circumferential position along a posterior wall of a blood vessel. The method includes advancing the catheter to a target longitudinal position within the blood vessel and positioning the array within the blood vessel so as to minimize interference by CRM leads or coils in the blood vessel during therapeutic delivery of energy using the array.

Claims (30)

1. A method for positioning an electrode array of a neuromodulation catheter at a target position along a posterior wall of a blood vessel for use in delivering therapeutic stimulus transvascularly to cardiac nerve fibers, the method comprising:

advancing the catheter into the blood vessel and positioning the electrode array into contact with the wall of the blood vessel in which a lead having lead insulation is positioned;

with the electrode array in contact with the wall of the blood vessel, selectively energizing electrodes of the array and measuring impedance between each of a plurality of electrode pairs of the array,

determining from the measured impedance which of the plurality of electrode pairs of the array has the highest measured impedance relative to the other of the plurality of electrode pairs to determine which of the plurality of electrode pairs are deployed in the presence of lead insulation of the lead, and

selecting pairs other than those determined to be in the presence of lead insulation; and

performing automatic response testing using each of the selected pairs by, for each of the selected pairs, energizing at least one electrode in the pair while monitoring the patient's heart rate, and determining whether said therapeutic energy results in a change to the patient's heart rate.

2. The method of claim 1 , wherein the step of performing automatic response testing includes

(a) determining the patient's heart rate;

(b) for each of said selected pairs, energizing said at least one electrode in the pair using stimulation parameters selected to capture the vagus nerve while determining the patient's heart rate and,

(c) if the heart rate determined in step (b) is not lower than the heart rate determined in step (a), repositioning the electrode array on the wall of the blood vessel and repeating step (b).

3. The method of claim 1 , wherein:

the method provides the catheter to have a catheter shaft, and the array comprises a pair of parallel elements having a space between them extending from the catheter, each element comprising a flexible substrate having electrodes thereon, each element further comprising a free end; and wherein

the method further comprises;

positioning the catheter shaft to run longitudinally along a wall of the blood vessel; and

positioning the array within the blood vessel so as to position the parallel elements longitudinally on opposite sides of the lead.

4. A method for positioning an electrode array of a neuromodulation catheter at a target position along a posterior wall of a blood vessel for use in delivering therapeutic stimulus transvascularly to cardiac nerve fibers, the method comprising:

advancing the catheter into the blood vessel and positioning the electrode array into contact with the wall of the blood vessel in which a CRM coil is positioned;

with the electrode array in contact with the wall of the blood vessel, selectively energizing electrodes of the array and measuring impedance between each of a plurality of electrode pairs of the array,

determining from the measured impedance which of the plurality of electrode pairs of the array have low measured impedance relative to the other of the plurality of electrode pairs to determine which of the plurality of electrode pairs are deployed in the presence of the CRM coil, and

selecting pairs other than those determined to be in the presence of the CRM coil; and

performing automatic response testing using each of the selected pairs by, for each of the selected pairs, energizing at least one electrode in the pair while monitoring the patient's heart rate, and determining whether said therapeutic energy results in a change to the patient's heart rate.

5. The method of claim 4 , wherein the step of performing automatic response testing includes

(a) determining the patient's heart rate;

(b) for each of said selected pairs, energizing said at least one electrode in the pair using stimulation parameters selected to capture the vagus nerve while determining the patient's heart rate and,

(c) if the heart rate determined in step (b) is not lower than the heart rate determined in step (a), repositioning the electrode array on the wall of the blood vessel and repeating step (b).

6. The method of claim 4 , wherein:

the method provides the catheter to have a catheter shaft and the array comprises a pair of parallel elements having a space between them extending from the catheter, each element comprising a flexible substrate having electrodes thereon, each element further comprising a free end; and wherein

the method further comprises;

positioning the catheter shaft to run longitudinally along a wall of the blood vessel; and

positioning the array within the blood vessel so as to position the parallel elements longitudinally on opposite sides of the CRM coil.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2020
From: NEUROTRONIK IP HOLDING (JERSEY) LIMITED
To: NUXCEL LIMITED
Reel/Frame 052794/0013 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2020
From: MASSON, STEPHEN C
To: NEUROTRONIK IP HOLDING (JERSEY) LIMITED
Reel/Frame 052581/0055 →
Continuity (5)
Continuation 15798356 · Oct 30, 2017
Continuation 14085773 · Nov 20, 2013
Provisional Application 61728799 · Nov 20, 2012
Provisional Application 61728805 · Nov 20, 2012
Related Publication 20190186702A1 · Jun 20, 2019
Cited By (4)
US 12,527,519 US 12,569,686 US 12,599,339 US 12,635,953